505 related articles for article (PubMed ID: 24126545)
21. Pharmacological management of obesity.
Hanif MW; Kumar S
Expert Opin Pharmacother; 2002 Dec; 3(12):1711-8. PubMed ID: 12472368
[TBL] [Abstract][Full Text] [Related]
22. Obesity Pharmacotherapy.
Saunders KH; Umashanker D; Igel LI; Kumar RB; Aronne LJ
Med Clin North Am; 2018 Jan; 102(1):135-148. PubMed ID: 29156182
[TBL] [Abstract][Full Text] [Related]
23. Obesity and cardiovascular physiology: impact of some pharmacological agents.
Chaput JP; Bérubé-Parent S; Tremblay A
Curr Vasc Pharmacol; 2005 Apr; 3(2):185-93. PubMed ID: 15853638
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity.
Gray LJ; Cooper N; Dunkley A; Warren FC; Ara R; Abrams K; Davies MJ; Khunti K; Sutton A
Obes Rev; 2012 Jun; 13(6):483-98. PubMed ID: 22288431
[TBL] [Abstract][Full Text] [Related]
25. Drug treatment of obesity in the cardiovascular patient.
Charakida M; Tousoulis D; Finer N
Curr Opin Cardiol; 2013 Sep; 28(5):584-91. PubMed ID: 23928924
[TBL] [Abstract][Full Text] [Related]
26. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
[TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy for obesity in menopausal women.
Samat A; Rahim A; Barnett A
Menopause Int; 2008 Jun; 14(2):57-62. PubMed ID: 18519266
[TBL] [Abstract][Full Text] [Related]
28. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacotherapy of obesity].
Rotthoff T; Scherbaum WA
Med Monatsschr Pharm; 2006 Dec; 29(12):433-8; quiz 439-40. PubMed ID: 17220037
[TBL] [Abstract][Full Text] [Related]
30. New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia).
Shyh G; Cheng-Lai A
Cardiol Rev; 2014; 22(1):43-50. PubMed ID: 24304809
[TBL] [Abstract][Full Text] [Related]
31. Pharmacotherapy for obesity.
Li M; Cheung BM
Br J Clin Pharmacol; 2009 Dec; 68(6):804-10. PubMed ID: 20002075
[TBL] [Abstract][Full Text] [Related]
32. [New therapeutic aspects for the control of risk factors in obesity].
Formiguera X; Sierra A
Med Clin (Barc); 2007 Apr; 128(13):508-14. PubMed ID: 17419915
[TBL] [Abstract][Full Text] [Related]
33. A review of the metabolic effects of controlled-release Phentermine/Topiramate.
Kiortsis DN
Hormones (Athens); 2013; 12(4):507-16. PubMed ID: 24457398
[TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy to reduce visceral fat.
Blackburn GL; Waltman BA
Clin Cornerstone; 2005; 7(2-3):52-60. PubMed ID: 16473261
[TBL] [Abstract][Full Text] [Related]
35. Drug treatment of obesity: current status and future prospects.
Kakkar AK; Dahiya N
Eur J Intern Med; 2015 Mar; 26(2):89-94. PubMed ID: 25634851
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.
Norris SL; Zhang X; Avenell A; Gregg E; Schmid CH; Lau J
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD004096. PubMed ID: 15674929
[TBL] [Abstract][Full Text] [Related]
37. Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.
Caterson ID; Finer N
Asia Pac J Clin Nutr; 2006; 15 Suppl():55-62. PubMed ID: 16928662
[TBL] [Abstract][Full Text] [Related]
38. Weight loss medications--where do they fit in?
Dixon JB
Aust Fam Physician; 2006 Aug; 35(8):576-9. PubMed ID: 16894428
[TBL] [Abstract][Full Text] [Related]
39. [Obesity: a review of currently used antiobesity drugs and new compounds in clinical development].
Zieba R
Postepy Hig Med Dosw (Online); 2007 Oct; 61():612-26. PubMed ID: 17971763
[TBL] [Abstract][Full Text] [Related]
40. Phentermine and topiramate extended-release for the obesity: new kids on the block.
Katsi V; Marketou M; Kallistratos MS; Tousoulis D; Makris T; Manolis AJ; Vardas P; Kallikazaros I
Recent Pat Cardiovasc Drug Discov; 2013 Apr; 8(1):35-41. PubMed ID: 23565717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
